Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
66.86
-2.84 (-4.07%)
At close: May 15, 2026, 4:00 PM EDT
66.50
-0.36 (-0.54%)
After-hours: May 15, 2026, 5:44 PM EDT
Disc Medicine Stock Forecast
Stock Price Forecast
The 10 analysts that cover Disc Medicine stock have a consensus rating of "Strong Buy" and an average price target of $98, which forecasts a 46.57% increase in the stock price over the next year. The lowest target is $79 and the highest is $125.
Price Target: $98 (+46.57%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 7 | 7 | 8 | 8 | 8 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +19.65% | May 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $78 → $79 | Buy | Maintains | $78 → $79 | +18.16% | Mar 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $114 → $83 | Strong Buy | Maintains | $114 → $83 | +24.14% | Feb 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $125 → $110 | Strong Buy | Maintains | $125 → $110 | +64.52% | Feb 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $153 → $125 | Buy | Maintains | $153 → $125 | +86.96% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
6.55M
Revenue Next Year
27.62M
from 6.55M
Increased by 321.89%
EPS This Year
-7.30
from -6.01
EPS Next Year
-7.70
from -7.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 74.1M | 56.5M | ||||||
| Avg | 6.5M | 27.6M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 762.7% | ||||||
| Avg | - | 321.9% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -6.59 | -6.14 | ||||||
| Avg | -7.30 | -7.70 | ||||||
| Low | -8.38 | -8.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.